Gianna Maria D.
- Country
- Italy
- Department
- UOC Ematologia
Research Overview
Data & Insights
Has run more than one trial at 4 of 16 partner sites.
Specializations
Hematologic Malignancies
This investigator specializes in treating complex blood disorders, with particular expertise in Hairy Cell Leukemia (HCL) and classical Hodgkin Lymphoma (cHL). Their research encompasses innovative therapeutic approaches for patients with challenging disease presentations.
- BRAF-mutated Hairy Cell Leukemia
- Relapsed/Refractory Hodgkin Lymphoma
- Treatment-resistant Blood Cancers
The investigator focuses on developing treatment solutions for patients who are either refractory to standard therapies or unsuitable for conventional chemotherapy approaches.
Targeted Therapies
The investigator explores novel targeted therapeutic combinations, including BRAF inhibitors, MEK inhibitors, and monoclonal antibodies. Their work emphasizes personalized treatment approaches based on specific molecular markers.
- Kinase Inhibitor Therapy
- Antibody-based Treatments
- Combination Treatment Strategies
Their research integrates multiple therapeutic modalities to address complex hematologic conditions and overcome treatment resistance.
Special Patient Populations
The investigator has particular interest in developing treatment options for medically complex patients and those who cannot receive standard chemotherapy treatments.
- Chemotherapy-unfit Patients
- Treatment-refractory Cases
- Patients with Comorbidities
Their work addresses the unique challenges of treating hematologic malignancies in patients with specific medical contraindications or previous treatment complications.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.